Arvee Laboratories Intrinsic Value
Arvee Laboratories (ARVEE) median intrinsic value is ₹49.15 from 8 valuation models (range ₹33–₹66), vs current price ₹163.82 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit Arvee Laboratories share price today.
ARVEE Valuation Methods Summary — DCF, Graham Number & P/E
Arvee Laboratories intrinsic value across 8 models vs current price ₹163.82 — upside/downside and value range per method. Browse ARVEE quarterly financials for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹49.15 | ₹39.32 - ₹58.98 | -70.0% | EPS: ₹0.40, Sector P/E: 12x |
| Book Value Method | asset | ₹32.76 | ₹29.48 - ₹36.04 | -80.0% | Book Value/Share: ₹28.18, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹49.15 | ₹44.23 - ₹54.07 | -70.0% | Revenue/Share: ₹24.55, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹65.53 | ₹58.98 - ₹72.08 | -60.0% | EBITDA: ₹2.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹65.53 | ₹52.42 - ₹78.64 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹49.15 | ₹44.23 - ₹54.07 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹49.15 | ₹44.23 - ₹54.07 | -70.0% | Revenue Growth: -9.9%, Adj P/E: 8.0x |
| Graham Defensive Method | conservative | ₹49.15 | ₹44.23 - ₹54.07 | -70.0% | EPS: ₹0.40, BVPS: ₹28.18 |
ARVEE Intrinsic Value vs Market Price — All Valuation Models
Arvee Laboratories fair value range ₹33–₹66 vs current market price ₹163.82 across 8 valuation models. Compare with ARVEE fair price to assess whether the stock is under or overvalued.
ARVEE Intrinsic Value Analysis — Undervalued or Overvalued?
Arvee Laboratories median intrinsic value ₹49.15, current price ₹163.82 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of ARVEE?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Arvee Laboratories (ARVEE) is ₹49.15 (median value). With the current market price of ₹163.82, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹32.76 to ₹65.53, indicating ₹32.76 - ₹65.53.
Is ARVEE undervalued or overvalued?
Based on our multi-method analysis, Arvee Laboratories (ARVEE) appears to be trading above calculated value by approximately 70.0%.
ARVEE Financial Health — Key Ratios vs Industry Benchmarks
Arvee Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 11.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.23 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 3.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.71x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
ARVEE Cash Flow Quality — Operating & Free Cash Flow
Arvee Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹4 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2020 | ₹10 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |